Clinical Trial Update: Repeated Methotrexate for Proliferative Vitreoretinopathy Grade C [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on repeated methotrexate for proliferative vitreoretinopathy (Grade C) in Phase 2/Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Vitreoretinopathy

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Proliferative Vitreoretinopathy | Phase 2, Phase 3 | Status: UNKNOWN